Ireland
--:--IST
Recruiting Not applicable

Evaluation of the Effects of Laughter Yoga

NCT07524231 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-03-10
Last updated
2026-04-13

Condition(s) studied

Multiple Sclerosis

Investigational drug(s) / intervention(s)

Laughter Yoga

Laughter Yoga: A complementary intervention including breathing exercises, stretching, relaxation techniques, and laughter exercises applied to patients with Multiple Sclerosis.

Study summary

This randomized controlled study aims to evaluate the effects of laughter yoga on pain intensity, fatigue, and beta-endorphin levels in patients with Multiple Sclerosis. Laughter yoga, a complementary therapy combining breathing exercises and laughter techniques, may help improve symptom management and psychological well-being in individuals with MS.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * • Being over 18 years old * Being able to communicate adequately * Volunteering to participate in the research Exclusion Criteria: * Unwillingness to participate in the study Having severe cognitive impairment that prevents understanding or participation in the intervention Having a psychiatric disorder that may affect participation in the study Experiencing an acute MS relapse during the study period Having another serious neurological or chronic disease that may affect the study outcomes Regular participation in another complementary therapy program similar to laughter yoga Communication problems that prevent participation in the intervention sessions

Primary outcome measure(s)

  • Change in pain intensity measured by Visual Analog Scale (VAS) at [time point] — Baseline and week 4
    Pain intensity will be assessed using the Visual Analog Scale (VAS), a 10 cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will indicate their pain level by marking on the scale, and the score will be determined by measuring the distance in centimeters or millimeters.

Trial sites (1)

FacilityCityRegionStatus
Gül DURAL Elâzığ Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07524231 on ClinicalTrials.gov ↗ ← All trials in Turkey